Martin Florian, Thomson Ty M, Sewer Alain, Drubin David A, Mathis Carole, Weisensee Dirk, Pratt Dexter, Hoeng Julia, Peitsch Manuel C
Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, Neuchâtel, 2000, Switzerland.
BMC Syst Biol. 2012 May 31;6:54. doi: 10.1186/1752-0509-6-54.
High-throughput measurement technologies produce data sets that have the potential to elucidate the biological impact of disease, drug treatment, and environmental agents on humans. The scientific community faces an ongoing challenge in the analysis of these rich data sources to more accurately characterize biological processes that have been perturbed at the mechanistic level. Here, a new approach is built on previous methodologies in which high-throughput data was interpreted using prior biological knowledge of cause and effect relationships. These relationships are structured into network models that describe specific biological processes, such as inflammatory signaling or cell cycle progression. This enables quantitative assessment of network perturbation in response to a given stimulus.
Four complementary methods were devised to quantify treatment-induced activity changes in processes described by network models. In addition, companion statistics were developed to qualify significance and specificity of the results. This approach is called Network Perturbation Amplitude (NPA) scoring because the amplitudes of treatment-induced perturbations are computed for biological network models. The NPA methods were tested on two transcriptomic data sets: normal human bronchial epithelial (NHBE) cells treated with the pro-inflammatory signaling mediator TNFα, and HCT116 colon cancer cells treated with the CDK cell cycle inhibitor R547. Each data set was scored against network models representing different aspects of inflammatory signaling and cell cycle progression, and these scores were compared with independent measures of pathway activity in NHBE cells to verify the approach. The NPA scoring method successfully quantified the amplitude of TNFα-induced perturbation for each network model when compared against NF-κB nuclear localization and cell number. In addition, the degree and specificity to which CDK-inhibition affected cell cycle and inflammatory signaling were meaningfully determined.
The NPA scoring method leverages high-throughput measurements and a priori literature-derived knowledge in the form of network models to characterize the activity change for a broad collection of biological processes at high-resolution. Applications of this framework include comparative assessment of the biological impact caused by environmental factors, toxic substances, or drug treatments.
高通量测量技术产生的数据集有潜力阐明疾病、药物治疗和环境因素对人类的生物学影响。科学界在分析这些丰富的数据源以更准确地表征在机制层面受到干扰的生物学过程方面面临着持续的挑战。在此,一种新方法建立在先前的方法之上,即利用因果关系的先验生物学知识来解释高通量数据。这些关系被构建成描述特定生物学过程(如炎症信号传导或细胞周期进程)的网络模型。这使得能够定量评估对给定刺激的网络扰动。
设计了四种互补方法来量化网络模型所描述过程中治疗诱导的活性变化。此外,还开发了配套统计方法来确定结果的显著性和特异性。这种方法被称为网络扰动幅度(NPA)评分,因为针对生物网络模型计算治疗诱导扰动的幅度。NPA方法在两个转录组数据集上进行了测试:用促炎信号介质TNFα处理的正常人支气管上皮(NHBE)细胞,以及用CDK细胞周期抑制剂R547处理的HCT116结肠癌细胞。每个数据集根据代表炎症信号传导和细胞周期进程不同方面的网络模型进行评分,并将这些分数与NHBE细胞中通路活性的独立测量值进行比较以验证该方法。与NF-κB核定位和细胞数量相比,NPA评分方法成功地量化了每个网络模型中TNFα诱导扰动的幅度。此外,还切实确定了CDK抑制对细胞周期和炎症信号传导的影响程度和特异性。
NPA评分方法利用高通量测量和以网络模型形式的先验文献衍生知识,以高分辨率表征广泛的生物学过程的活性变化。该框架的应用包括对环境因素、有毒物质或药物治疗所造成的生物学影响的比较评估。